Compare EPOW & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EPOW | POM |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | China | China |
| Employees | N/A | N/A |
| Industry | Business Services | Other Specialty Stores |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.0M | 38.8M |
| IPO Year | 2021 | 2025 |
| Metric | EPOW | POM |
|---|---|---|
| Price | $0.82 | $0.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 144.0K | ★ 463.6K |
| Earning Date | 05-15-2025 | 12-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $70,681,651.00 | $51,210,721.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 51.60 | 12.13 |
| 52 Week Low | $0.66 | $0.21 |
| 52 Week High | $1.86 | $6.43 |
| Indicator | EPOW | POM |
|---|---|---|
| Relative Strength Index (RSI) | 45.04 | 28.17 |
| Support Level | $0.73 | $0.21 |
| Resistance Level | $0.82 | $0.25 |
| Average True Range (ATR) | 0.07 | 0.03 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 58.21 | 38.33 |
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.